Xcopri

Chemical Namecenobamate
Dosage FormTablet (oral; 12.5 mg, 25 mg, 50 mg, 100 mg, 150 mg, 200 mg)
Drug ClassInhibitors
SystemNervous
CompanySK Life Science
Approval Year2019

Indication

  • Xcopri is indicated for the treatment of partial-onset seizures in adult patients.
Last updated on 10/30/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Xcopri (cenobamate) Prescribing Information2020SK Life Sciences